Long-term results of a multicentre randomised, comparative phase III trial of CHOP versus CNOP regimens in patients with intermediate-and high-grade non-Hodgkin's lymphomas

This publication has 11 references indexed in Scilit:

• Randomized comparison of MACOP-B with CHOP in patients with intermediate-grade non-Hodgkin's lymphoma. The Australian and New Zealand Lymphoma Group.
  Journal of Clinical Oncology, 1994
• Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's Lymphoma
  New England Journal of Medicine, 1993
• Comparison of a Second-Generation Combination Chemotherapeutic Regimen (m-BACOD) with a Standard Regimen (CHOP) for Advanced Diffuse Non-Hodgkin's Lymphoma
  New England Journal of Medicine, 1992
• Results of a randomized study of previously-untreated intermediate and high grade lymphoma using CHOP versus CNOP
  Annals of Oncology, 1992
• Multicenter clinical trial of mitoxantrone in non-Hodgkin's lymphoma and Hodgkin's disease.
  Journal of Clinical Oncology, 1991
• Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial.
  Journal of Clinical Oncology, 1991
• Unfavorable histologies of non-Hodgkin's lymphoma treated with ProMACE-CytaBOM: a groupwide Southwest Oncology Group study.
  Journal of Clinical Oncology, 1990
• A randomized multicenter trial comparing mitoxantrone, cyclophosphamide, and fluorouracil with doxorubicin, cyclophosphamide, and fluorouracil in the therapy of metastatic breast carcinoma.
  Journal of Clinical Oncology, 1988
• National cancer institute sponsored study of classifications of non-hodgkin's lymphomas. Summary and description of a working formulation for clinical usage
  Cancer, 1982
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958